Skip to main content
. 2016 Jul 2;2016(7):CD010832. doi: 10.1002/14651858.CD010832.pub2

2.9. Analysis.

Comparison 2 FLUPHENAZINE (ORAL) vs RISPERIDONE, Outcome 9 Adverse effects: 5. Average endpoint weight loss (kg) (skewed data).

Adverse effects: 5. Average endpoint weight loss (kg) (skewed data)
Study Intervention Mean(kg) SD N
short term (up to 12 weeks)
Conley 2005 Fluphenazine ‐2.6 5.7 13
Conley 2005 Risperidone ‐0.65 2.43 13